Bluebird Bio Revenue 2012-2021 | BLUE

Bluebird Bio revenue from 2012 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Bluebird Bio Annual Revenue
(Millions of US $)
2020 $251
2019 $45
2018 $55
2017 $35
2016 $6
2015 $14
2014 $25
2013 $20
2012 $0
2011 $1
Bluebird Bio Quarterly Revenue
(Millions of US $)
2021-06-30 $7
2021-03-31 $13
2020-12-31 $11
2020-09-30 $19
2020-06-30 $199
2020-03-31 $22
2019-12-31 $10
2019-09-30 $9
2019-06-30 $13
2019-03-31 $12
2018-12-31 $19
2018-09-30 $12
2018-06-30 $8
2018-03-31 $16
2017-12-31 $4
2017-09-30 $8
2017-06-30 $17
2017-03-31 $7
2016-12-31 $2
2016-09-30 $2
2016-06-30 $2
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $5
2015-03-31 $6
2014-12-31 $6
2014-09-30 $6
2014-06-30 $6
2014-03-31 $6
2013-12-31 $6
2013-09-30 $6
2013-06-30 $6
2013-03-31 $1
2012-12-31
2012-09-30 $0
2012-06-30 $0
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.412B $0.251B
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00